These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Looking forward: the expanding utility of sumatriptan and naratriptan. Cady R Cephalalgia; 2001; 21 Suppl 1():35-8. PubMed ID: 11678821 [No Abstract] [Full Text] [Related]
5. Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew. Goldstein D Cephalalgia; 1999 Jun; 19(5):536-7. PubMed ID: 10403072 [No Abstract] [Full Text] [Related]
6. Building on the sumatriptan experience: the development of naratriptan. Connor HE Cephalalgia; 2001; 21 Suppl 1():32-4. PubMed ID: 11678820 [No Abstract] [Full Text] [Related]
7. Cerebral vasospasm from sumatriptan. Dash S; Bogdanova O; Xavier A; Farkas J; Pullicino P Neurology; 2004 Dec; 63(11):2128. PubMed ID: 15596760 [No Abstract] [Full Text] [Related]
8. Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial. Mathew NT; Kailasam J; Gentry P; Chernyshev O Headache; 2000 Jun; 40(6):464-5. PubMed ID: 10849042 [TBL] [Abstract][Full Text] [Related]
9. How to assess patient preference of migraine treatments. Dahlöf C Cephalalgia; 1999 Jul; 19 Suppl 24():2-5; discussion 5-6. PubMed ID: 10526675 [No Abstract] [Full Text] [Related]
10. Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine. O'Quinn S; Davis RL; Gutterman DL; Pait GD; Fox AW Cephalalgia; 1999 May; 19(4):223-31; discussion 200. PubMed ID: 10376167 [TBL] [Abstract][Full Text] [Related]
11. Cardiac arrest and myocardial infarction immediately after sumatriptan injection. Main ML; Ramaswamy K; Andrews TC Ann Intern Med; 1998 May; 128(10):874. PubMed ID: 9599209 [No Abstract] [Full Text] [Related]
12. Ischemic colitis and sumatriptan use. Knudsen JF; Friedman B; Chen M; Goldwasser JE Arch Intern Med; 1998 Sep; 158(17):1946-8. PubMed ID: 9759693 [TBL] [Abstract][Full Text] [Related]
14. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142 [TBL] [Abstract][Full Text] [Related]
15. Serotonin 1D (5-HT1D) agonists and other agents in acute migraine. Mathew NT Neurol Clin; 1997 Feb; 15(1):61-83. PubMed ID: 9058397 [TBL] [Abstract][Full Text] [Related]
16. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients]. Géraud G; Valette C Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800 [TBL] [Abstract][Full Text] [Related]
17. A case of sumatriptan-induced intestinal ischemia. Repaka A; Wenger J; Sitaraman SV J Gastroenterol; 2006 Feb; 41(2):177-8. PubMed ID: 16568377 [No Abstract] [Full Text] [Related]
18. Effects of the anti-migraine drug sumatriptan on muscle energy metabolism: relationship to side-effects. Boska MD; Welch KM; Schultz L; Nelson J Cephalalgia; 2000 Feb; 20(1):39-44. PubMed ID: 10817445 [TBL] [Abstract][Full Text] [Related]
19. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment. Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662 [TBL] [Abstract][Full Text] [Related]